“New” cardiovascular risk factors in patients with chronic kidney disease: Role of folic acid treatment
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 67 (93) , S39-S43
- https://doi.org/10.1111/j.1523-1755.2005.09309.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive proteinKidney International, 2004
- Traditional Cardiovascular Disease Risk Factors in Dialysis Patients Compared with the General PopulationJournal of the American Society of Nephrology, 2002
- Associations of homocysteine, C-reactive protein and cardiovascular disease in patients with renal diseaseCurrent Opinion in Nephrology and Hypertension, 2001
- Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysisNephrology Dialysis Transplantation, 2000
- Role of Oxidant Stress in Endothelial Dysfunction Produced by Experimental Hyperhomocyst(e)inemia in HumansCirculation, 1999
- Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease.Nephrology Dialysis Transplantation, 1997
- Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control studyAtherosclerosis, 1996
- Homocysteine and vascular diseaseNature Medicine, 1996
- Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review)Free Radical Research Communications, 1992
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989